Yang He

Title: Innovations of Inventor Yang He

Introduction

Yang He is an accomplished inventor based in Hubei, China. With a total of 5 patents to his name, Yang has made significant contributions to the field of biotechnology, particularly in the extraction and purification of recombinant human serum albumin (rHSA).

Latest Patents

Among Yang He's notable patents, two recent innovations stand out:

1. **Method for isolating and purifying recombinant human serum albumin from transgenic rice grain** - This method involves a systematic approach to extract rHSA, which includes cation exchange chromatography, anion exchange chromatography, and hydrophobic chromatography. The process is lauded for its low cost and ease of operation, ultimately yielding rHSA with a purity of about 99% as determined by high-performance liquid chromatography (HPLC).

2. **Method for extracting recombinant human serum albumin from transgenic rice grain** - This technique focuses on grinding dehusked rice containing rHSA and extracting it with a specifically formulated buffer. The resultant solution boasts a concentration of rHSA at approximately 650-660 µg/mL, significantly enhancing yield while reducing non-target protein by 2.46 times.

Career Highlights

Yang He has played a crucial role in advancing biotechnological methods through his innovative patents. His work has been developed in collaboration with notable companies such as Healthgen Biotechnology Co., Ltd. and Healthgen Biotechnology Corporation, where his research has focused on utilizing transgenic plants for biopharmaceutical applications.

Collaborations

Throughout his career, Yang has collaborated with distinguished colleagues in the field, including Daichang Yang and Guangfei Li. These partnerships have fostered an environment of shared knowledge, driving the success of their innovative endeavors.

Conclusion

As a dedicated inventor, Yang He continues to pave the way for advancements in biotechnology. His pioneering methods for isolating and purifying recombinant human serum albumin from transgenic sources not only demonstrate his ingenuity but also hold great promise for the future of biopharmaceutical production. Through collaboration and a commitment to innovation, Yang's contributions are bound to influence the industry significantly.